Table 1.
Patient characteristics by baseline HDL-c level (in mg/dl) in those with CKD
| Variable | Overall (N=38377) | ≤30 (N=2463) | 31–40 (N=7530) | 41–50 (N=10369) | 51–60 (N=8223) | >60 (N=9792) | p-value |
|---|---|---|---|---|---|---|---|
| Age | 71.7+11.2 | 68.8+12.1 | 70.3+11.2 | 71.4+11.1 | 72.6+10.9 | 73.1+11.2 | <0.001a |
| Male gender, % | 44.2 | 70.2 | 64.7 | 49.6 | 36.5 | 22.7 | <0.001c |
| African American,% | 12.0 | 7.1 | 8.7 | 10.4 | 12.5 | 6.9 | <0.001c |
| Smoking | <0.001c | ||||||
| No | 81.3 | 60.6 | 76.0 | 82.1 | 85.1 | 86.6 | |
| Yes | 7.0 | 9.0 | 8.6 | 7.2 | 5.9 | 5.9 | |
| Missing | 11.7 | 30.4 | 15.4 | 10.7 | 9.0 | 7.6 | |
| BMI | <0.001c | ||||||
| <18.5 kg/m2 | 0.88 | 0.53 | 0.39 | 0.56 | 0.72 | 1.8 | |
| 18.5–24.9 kg/m2 | 20.4 | 13.4 | 13.6 | 15.8 | 20.7 | 32.1 | |
| 25–29.9 kg/m2 | 34.9 | 30.2 | 33.1 | 35.8 | 36.3 | 35.3 | |
| 30–34.9 kg/m2 | 22.8 | 25.2 | 27.3 | 24.3 | 22.6 | 17.1 | |
| 35–39.9 kg/m2 | 10.4 | 13.7 | 12.8 | 11.7 | 9.7 | 6.8 | |
| >40 kg/m2 | 7.3 | 9.5 | 8.9 | 8.2 | 7.2 | 4.6 | |
| Missing | 3.4 | 7.6 | 3.9 | 3.6 | 2.7 | 2.3 | |
| eGFR, ml/min/1.73 m2 | 48.7+9.8 | 45.9+11.0 | 48.0+10.1 | 48.7+9.9 | 49.1+9.5 | 49.5+9.3 | <0.001a |
| eGFR categories | <0.001c | ||||||
| 45–59 | 71.5 | 61.2 | 68.9 | 71.5 | 73.3 | 74.5 | |
| 30–44 | 22.1 | 27.5 | 23.5 | 22.0 | 21.3 | 20.5 | |
| 15–29 | 6.4 | 11.3 | 7.6 | 6.4 | 5.4 | 5.0 | |
| Diabetes, % | 29.8 | 32.4 | 37.8 | 33.2 | 27.9 | 20.8 | <0.001c |
| Hypertension, % | 87.2 | 66.1 | 83.6 | 88.6 | 90.2 | 91.5 | <0.001c |
| CAD, % | 24.2 | 26.3 | 30.9 | 26.4 | 23.0 | 17.3 | <0.001c |
| CHF, % | 7.8 | 11.2 | 9.9 | 7.8 | 6.4 | 6.5 | <0.001c |
| Cerebrovascular | |||||||
| disease, % | 10.4 | 8.4 | 10.6 | 10.8 | 10.8 | 9.9 | 0.002c |
| Peripheral vascular | |||||||
| disease, % | 3.7 | 4.5 | 4.2 | 3.8 | 3.4 | 3.2 | <0.001c |
| Hyperlipidemia, % | 89.0 | 75.6 | 87.0 | 89.4 | 90.7 | 91.9 | <0.001c |
| ACEI/ARBs, % | 66.6 | 58.5 | 70.4 | 69.4 | 67.3 | 62.1 | <0.001c |
| Statin use, % | 65.8 | 52.6 | 66.3 | 69.2 | 69.3 | 61.9 | <0.001c |
| Beta-Blocker use, % | 55.7 | 56.4 | 62.1 | 57.9 | 55.2 | 48.5 | <0.001c |
| Diuretic use, % | 67.5 | 58.3 | 66.3 | 69.3 | 68.2 | 68.2 | <0.001c |
| SBP (mm Hg) | 130.2+19.0 | 127.5+20.2 | 129.5+19.2 | 130.0+19.0 | 130.4+18.7 | 131.1+18.7 | <0.001a |
| DBP (mm Hg) | 73.1+11.0 | 71.4+11.8 | 72.7+11.3 | 73.1+11.0 | 73.2+10.7 | 73.5+10.9 | <0.001a |
| Serum albumin | 4.1+0.44 | 3.8+0.61 | 4.1+0.45 | 4.1+0.42 | 4.2+0.39 | 4.2+0.39 | <0.001a |
| Hemoglobin | 13.0+1.7 | 12.7+2.0 | 13.1+1.9 | 13.1+1.8 | 13.0+1.6 | 12.9+1.5 | <0.001a |
| Serum triglycerides | 127.0[90.0,180.0] | 175.0[118.0,263.0] | 160.0[113.0,223.0] | 138.0[100.0,187.0] | 119.0[88.0,162.0] | 97.0[73.0,131.0] | <0.001b |
| Total cholesterol | 179.9±45.0 | 150.5±49.4 | 164.6±42.1 | 175.6±42.0 | 184.3±41.9 | 199.9±42.0 | <0.001a |
| LDL cholesterol | 98.3±36.1 | 80.9±40.8 | 90.9±33.7 | 98.5±35.1 | 101.7±36.1 | 103.7±36.0 | <0.001a |
| Proteinuria, % | 24.8 | 34.4 | 29.1 | 25.1 | 22.6 | 20.1 | <0.001c |
| Malignancy, % | 18.6 | 14.9 | 18.1 | 18.8 | 19.8 | 18.9 | <0.001c |
| Insurance | <0.001c | ||||||
| Medicaid | 0.30 | 0.41 | 0.31 | 0.36 | 0.26 | 0.23 | |
| Medicare | 79.4 | 74.1 | 76.5 | 78.7 | 81.5 | 82.0 | |
| Missing | 3.4 | 6.2 | 3.7 | 3.5 | 3.1 | 2.7 | |
| Other | 16.9 | 19.3 | 19.5 | 17.5 | 15.2 | 15.1 |
Values presented as mean+SD, percent, or median [P25, P75]
ANOVA,
Kruskal-Wallis test,
Chi-square test